Breast cancer and a new variant of treatment

• April 20, 2024

The Spanish Research Group in Breast cancer (GEICAM) has established a new paradigm for the treatment of this cancer, when it has not yet affected the lymph nodes. It is about operating and applying chemotherapy, with the novelty that it is added docetaxel . This reduces relapses by 32%; even 90% of those affected with which they have experienced no relapse after six years of treatment. The work, which has published The New England Journal of Medicine, endorses the use of the drug in early phases of the appearance of the tumor, use that European Medicines Agency just approved This treatment has been implemented in Spain, fully in no less than 500 hospitals. It is expected that the results will continue to be promising, so that in the future it can be extended to the rest of the countries, among which Mexico would be included .

East medicine It is especially indicated in the case of breast cancer. Thanks to the screening campaigns for mammograms, more and more are detected during the early stage of the illness.